ALLR

NASD Allarity Therapeutics, Inc.

Nov 4, 2026 · 9:49 AM ET DELAYED Market Open

$1.15 ↑ +0.02 (+1.77%) Trading Up from the previous close of $1.13

YTD change: +6.48%
vs 20-day SMA: +25.82%
vs 200-day SMA: -5.48%

Price ranges

Previous day

$0.98 $1.13

open $0.98 close $1.13

+$0.15 (+15.29%)

Today

$0.00 $0.00

open $1.15 now $1.15

+$0.00 (+0.00%)

Past week

$0.85 $1.13

from $0.92 now $1.15

+$0.23 (+25.00%)

Past month

$0.80 $1.13

from $0.99 now $1.15

+$0.16 (+16.72%)

This year

$0.77 $1.84

from $1.08 now $1.15

+$0.07 (+6.48%)

Price & Performance

-0.12 (-9.60%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good

The stock is 100.0% away from all-time highs of $764,400.00
ALLR is up 6% since the beginning of the year
ALLR is down 7% over the past 12 months
ALLR is up 17% over the past 1 month
1% of all ALLR investors are betting against ALLR

ALLR reads very good: price sits above one of the two key moving averages, the 12-month move is -8.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No

EPS $-0.21

Earnings momentum N/A Quarterly EPS growth

Quarterly change N/A

Valuation

P/E ratio N/A

Enterprise value $13.3M

Beta 0.89

Balance sheet & scale

IncomeN/A

Revenue$345.0K

Cash$27.0M

Debt$22.3K

Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD

Sector Manufacturing

Sub Sector Chemical Manufacturing

Market cap $18.3M

Allarity Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing personalized cancer treatments. The company is focused on development of stenoparib, a novel PARP and tankyrase inhibitor for advanced ovarian cancer patients, using its DRP technology to develop a companion diagnostic that can be used to select those patients expected to derive the greatest clinical benefit from stenoparib. Allarity Therapeutics was founded by Steen Knudsen and Thomas H. Jensen in 2004 and is headquartered in Tarpon Springs, FL.

Competitor comparison

Ticker	Company	Price	Change
LLY	Eli Lilly and Company	$1,409.38	-0.11%
JNJ	Johnson & Johnson	$266.17	-1.62%
ABBV	AbbVie, Inc.	$286.00	-0.98%
MRK	Merck & Co., Inc.	$144.67	-2.49%
RHHVF	Roche Holding Ltd	$481.54	-0.71%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.